Clinical Trial Update: S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer [Phase 3]

View source ↗

Summary

The Phase 3 trial S0227 evaluating cisplatin with paclitaxel or gemcitabine for recurrent, persistent, or metastatic cervical cancer has been withdrawn. No stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Cervical Cancer | Phase 3 | Status: WITHDRAWN